- News & Blogs
- Education & Resources
- Online Forum
|Richard E. Anderson, MD, FACP|
Richard E. Anderson, MD, FACP, is chairman and chief executive officer of The Doctors Company, the nation’s largest physician-owned medical malpractice insurance provider. Dr. Anderson was a clinical professor of medicine at the University of California, San Diego, and is past chairman of the Department of Medicine at Scripps Memorial Hospital, where he served as senior oncologist for eighteen years.
Dr. Anderson serves on the Board of Directors of the National Patient Safety Foundation. He also sits on the Board of Overseers of the RAND Institute for Civil Justice, the Board of Directors of Californians Allied for Patient Protection (CAPP), and the Board of Directors of the Physician Insurers Association of America (PIAA).
Dr. Anderson is the editor of the book Medical Malpractice: A Physician’s Sourcebook and the author of a number of peer-reviewed publications on medical malpractice, the Harvard Medical Practice Study, and the impact of defensive medicine. He has been invited to address numerous medical and legal forums. These include the American College of Cardiology, American College of Surgeons, the American College of Physicians, the American Association of Neurological Surgeons, the College of American Pathologists, the American Society of Plastic Surgeons, the American Medical Association, the academic medical centers of Stanford, UCLA, UCSD, Case Western, and the Cleveland Clinic, and the law schools of Columbia, Stanford and Northwestern. Industry presentations include the National Association of Insurance Commissioners (NAIC), the PIAA, the Professional Liability Underwriters Society (PLUS), Crittenden, the American Association of Health Plans, and the American Legislative Exchange Council (ALEC).
Dr. Anderson is the first recipient of the PLUS Foundation’s Award for Outstanding Leadership in Healthcare Professional Liability.
After graduating from Stanford Medical School, Dr. Anderson did his internship and residency at Harvard Medical School’s Beth Israel Hospital, followed by his postdoctoral fellowship in medical oncology at Stanford.